Literature DB >> 10604532

Kininergic system and arterial hypertension following chronic exposure to inorganic lead.

M Carmignani1, P Boscolo, A Poma, A R Volpe.   

Abstract

Rats were exposed for 10 months to 60 ppm of Pb (as acetate) in drinking water. Systolic and diastolic blood pressure and cardiac inotropism were increased by the metal, which reduced arterial blood flow and unaffected heart rate. The activities of plasma angiotensin I-converting enzyme (ACE) and kininase II were strongly augmented by Pb, suggesting markedly increased and decreased levels of plasma angiotensin II and bradykinin, respectively. Moreover, the Pb-exposed rats showed a lower increase of the plasma kallikrein and kininase I activities. These results are discussed in the context of the complex relationships linking the renin-angiotensin-aldosterone (RAA), kallikrein-kinin and other autacoidal, neurohumoral (e.g., catecholaminergic) and transductional systems (e.g., nitric oxide (NO)). Pb was confirmed to induce arterial hypertension and cardiovascular alterations at plasma levels similar to those observed in the general population or in subjects with short occupational exposure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604532     DOI: 10.1016/s0162-3109(99)00115-0

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  17 in total

Review 1.  Mechanisms of lead-induced hypertension and cardiovascular disease.

Authors:  Nosratola D Vaziri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

Review 2.  Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure.

Authors:  Natalia V Solenkova; Jonathan D Newman; Jeffrey S Berger; George Thurston; Judith S Hochman; Gervasio A Lamas
Journal:  Am Heart J       Date:  2014-07-22       Impact factor: 4.749

3.  Association of Blood Lead level with Elevated Blood Pressure in Hypertensive Patients.

Authors:  Abdullah A Alghasham; Abdel-Raheim M A Meki; Hisham A S Ismail
Journal:  Int J Health Sci (Qassim)       Date:  2011-01

Review 4.  Lead-induced hypertension: role of oxidative stress.

Authors:  Nosratola D Vaziri; Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

5.  A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the Department of Veterans Affairs Normative Aging Study.

Authors:  Marc G Weisskopf; Nitin Jain; Huiling Nie; David Sparrow; Pantel Vokonas; Joel Schwartz; Howard Hu
Journal:  Circulation       Date:  2009-09-08       Impact factor: 29.690

Review 6.  The vascular system as a target of metal toxicity.

Authors:  Walter C Prozialeck; Joshua R Edwards; Daniel W Nebert; James M Woods; Aaron Barchowsky; William D Atchison
Journal:  Toxicol Sci       Date:  2007-10-18       Impact factor: 4.849

7.  Acute lead exposure increases arterial pressure: role of the renin-angiotensin system.

Authors:  Maylla Ronacher Simões; Rogério F Ribeiro Júnior; Marcos Vinícius A Vescovi; Honério C de Jesus; Alessandra S Padilha; Ivanita Stefanon; Dalton V Vassallo; Mercedes Salaices; Mirian Fioresi
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

8.  Low-level lead exposure increases systolic arterial pressure and endothelium-derived vasodilator factors in rat aortas.

Authors:  Jonaina Fiorim; Rogério F Ribeiro Júnior; Edna A Silveira; Alessandra S Padilha; Marcos Vinícius A Vescovi; Honério C de Jesus; Ivanita Stefanon; Mercedes Salaices; Dalton V Vassallo
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

9.  Effects of low-level lead exposure on blood pressure and function of the rat isolated heart.

Authors:  Badalzadeh Reza; Norouzzadeh Ali; Heydari Azhdar; Asgari Alireza; Khoshbaten Ali
Journal:  Indian J Pharmacol       Date:  2008-03       Impact factor: 1.200

10.  Poorly controlled hypertension in a painter with chronic lead toxicity.

Authors:  H Hu
Journal:  Environ Health Perspect       Date:  2001-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.